Point72 Asset Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.1M | Buy |
|
|||||
|
2022
Q1 | $1.2M | Buy |
|
|||||
|
2021
Q4 | $2.12M | Buy |
|
|||||
|
2021
Q3 | $394K | Sell |
|
|||||
|
2021
Q2 | $8.77M | Buy |
|
|||||
|
2021
Q1 | $10.5M | Buy |
|
|||||
|
2020
Q4 | $9.43M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $4.07M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $647K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $2.45M | Buy |
|
|||||
|
2017
Q1 | $2.88M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.57M | Buy |
|